By The MacDiarmid Institute for Advanced Materials and Nanotechnology
Auramer Bio Ltd was established by former Principal Investigator and Co-Director and now Emeritus Investigator Professor Justin Hodgkiss. The company is developing aptamers; new antibodies made in the lab from DNA and designed to bind to very specific targets. Aptamers can target hormones for fertility treatment or methamphetamine for drug testing, etc.
Boutiq Science Ltd was founded by former Principal Investigator Professor Richard Tilley. Boutiq specialised in highly magnetic iron nanoparticles that could be used in medical imaging and other advanced applications, and in 2016 became a joint venture company with the University of South Australia. Australian medical technology company Ferronova uses a super-paramagnetic iron-oxide nanoparticle (SPION) tracer designed to enable radiation oncologists and surgeons to accurately map the lymphatic system with MRI.
CATEGORY
Twophold is a clean‑energy start-up established by Associate Investigator Dr Nate Davis. Twophold is working on materials that improve solar panel efficiency. In conventional solar cells, excess energy from high-energy light is lost as heat. TwoPhold captures this lost energy by splitting a single photon into two usable charges, generating more electricity from the same sunlight, enabling solar cells to move beyond the conventional ~32% efficiency limit and approach ~44%.
CATEGORY
Hi-Aspect Ltd was set up in 2015 by former Principal Investigator and now Emeritus Investigator Professor Juliet Gerrard, University of Auckland, to develop a new protein-based nanomaterial that can heal skin. Its applications include skincare products and gels, films and patches for use in wound dressings and cosmetics.
CATEGORY
